News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Clearmind Medicine and SciSparc Collaboration Yields Positive Results for its Psychedelic Combination Treatment
Clearmind Medicine
Blackhawk's Terp Wholesale LLC Expands Facility, Launches Retail Delivery
MindBio Therapeutics
Awakn Life Sciences CEO, Anthony Tennyson, Joins Dustin Robinson of Iter Investments for 'The Investor Hotseat' via Live Stream on May 26th
Awakn Life Sciences
COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting
Compass Pathways
MindMed Appoints Schond L. Greenway as Chief Financial Officer
Mind Medicine (MindMed)
Psychedelic Headlines | May 20th
Numinus
Mind Medicine (MindMed)
PsyBio Therapeutics
Awakn Life Sciences
Havn Life
Braxia Scientific Receives Health Canada Special Access Program Approval to Provide Psilocybin-Assisted Therapy for Depression in Ontario
Braxia Scientific Corp.
Mydecine Announces Size of Previously Announced Overnight Marketed Public Offering of Units
Mydecine Innovations Group
PharmAla Biotech & SABI Mind Announce MDMA Supply Agreement
Pharmala Biotech Holdings
U.K. Member of Parliament Crispin Blunt To Inaugurate Psilocybin Cultivation Facility At Optimi Health Grand Opening
Optimi Health
Clearmind Medicine Announces Successful Pre-Clinical Results in MEAI Treatment for Alcohol Consumption
Clearmind Medicine
MindMed Reports Topline Data From Phase 1 Trial of MM-110 in Development for the Treatment of Opioid Withdrawal
Mind Medicine (MindMed)
Awakn Life Sciences Completes World's First Ketamine Treatment Study for a Range of Behavioral Addictions
Awakn Life Sciences
Mydecine Overnight Marketed Public Offering of Units
Mydecine Innovations Group
Braxia Scientific CEO to Speak at American Psychiatric Association Annual Meeting on Treatment Resistant Depression and Ketamine Guidelines Published in American Journal of Psychiatry
Braxia Scientific Corp.
Nirvana Signs Letter of Intent with Innovate Phytotechnologies Inc.
Nirvana Life Sciences
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.